SPA Microgen (part of Nacimbio Holding of Rostec State Corporation) has received the approval of the Ministry of Health of Kyrgyzstan for the application of the RELATOX drug in the territory of the Republic for two new indications – treatment of chronic migraine and correction of neck wrinkles.
Read more
The Russian Ministry of Health has approved the expansion of indications for the use of botulinum toxin type A Relatox by SPA ‘Microgen’ (part of Nacimbio Holding of Rostec State Corporation) for the treatment of focal spasticity of arm muscles in adults.
Read more
